The effect of oral pregabalin on the minimum alveolar concentration of isoflurane in cats
Veterinary Anaesthesia and Analgesia · 2024
DOI: 10.1016/j.vaa.2024.04.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2024. Verfasst von Luting Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Anesthetics, Inhalation, Cross-Over Studies, Isoflurane, Pregabalin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To investigate the effect of three different doses of oral pregabalin on minimum alveolar concentration of isoflurane (MACISO) in cats. STUDY DESIGN: Prospective, randomized, placebo-controlled, blinded, crossover trial. ANIMALS: A group of eight healthy adult cats aged 24-48 months. METHODS: Cats were randomly assigned to three oral doses of pregabalin (low dose: 2.5 mg kg-1, medium dose: 5 mg kg-1, high dose: 10 mg kg-1) or placebo 2 hours before MACISO determination, with the multiple treatments administered with a minimum 7 day washout period. Anesthesia was induced and maintained with isoflurane in oxygen until endotracheal intubation was achieved, and maintained with isoflurane with volume-controlled ventilation. MACISO was determined in triplicate using the bracketing technique and tail clamp method 120 minutes after pregabalin or placebo administration. Physiologic variables (including heart rate and blood pressure) recorded during MACISO determination were averaged and compared between the pregabalin and placebo treatments. One-way analysis of variance and the Friedman test were used to assess the difference for normally and non-normally distributed data, respectively. The Tukey test was used as a post hoc analysis. Values of p < 0.05 were considered significant. RESULTS: The MACISO with the medium- and high-dose pregabalin treatments were 1.33 ± 0.21% and 1.23 ± 0.17%, respectively. These were significantly lower than MACISO after placebo treatment (1.62 ± 0.13%; p = 0.014, p < 0.001, respectively), representing a decrease of 18 ± 9% and 24 ± 6%. The mean plasma pregabalin concentration was negatively correlated with MACISO values. Physiologic variables did not differ significantly between treatments. CONCLUSIONS AND CLINICAL RELEVANCE: Doses of 5 or 10 mg kg-1 pregabalin, administered orally 2 hours before determining MACISO, had a significant isoflurane-sparing effect in cats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China.
- Ainuo Baisi Animal Hospital, Guangzhou, Guangdong, China.
- Department of Preventative Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China. Electronic address: yangzhen@njau.edu.cn.
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China; Nanjing Agricultural University Veterinary Teaching Hospital, Nanjing, Jiangsu, China…
Zitieren
APA
Luo, L., Chen, H., Zhu, Y., Wu, Y., Guo, W., Yang, Z., & Li, M. (2024). The effect of oral pregabalin on the minimum alveolar concentration of isoflurane in cats. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2024.04.007
Vancouver
Luo L, Chen H, Zhu Y, Wu Y, Guo W, Yang Z, et al. The effect of oral pregabalin on the minimum alveolar concentration of isoflurane in cats. Veterinary Anaesthesia and Analgesia. 2024. doi:10.1016/j.vaa.2024.04.007
BibTeX
@article{Luo2024,
author = {Luo, Luting and Chen, Hangbin and Zhu, Yunjie and Wu, Yue and Guo, Weibin and Yang, Zhen and Li, Meng},
title = {The effect of oral pregabalin on the minimum alveolar concentration of isoflurane in cats},
journal = {Veterinary Anaesthesia and Analgesia},
year = {2024},
doi = {10.1016/j.vaa.2024.04.007}
}
EUVIMED